Cerebellar Stimulation for Depression and Other Conditions

Cerebellar Stimulation and Cognitive Control

Recruiting N/A Interventional Study
Schizophrenia Autism Spectrum Disorder Bipolar Disorder Depression Parkinson Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Interventional
Purpose
Basic Science
Participants needed
200 (estimated)
Sponsor
Krystal Parker, PhD · Other
Who this trial is looking for

This trial is looking for patients with depression, autism, bipolar disorder, Parkinson's disease, or schizophrenia. Participants will receive cerebellar stimulation to see if it can help improve their mood and thinking abilities.

Are You a Good Fit for This Trial?
Rules you out Kidney diseaseClaustrophobiaSignificant heart diseaseAtrial fibrillationHemodynamic instabilityPregnancy or breastfeeding

You may be able to join if

  • I have a clinical diagnosis of depression, autism, bipolar disorder, Parkinson's disease, or schizophrenia.

You may not be able to join if

  • I have a history of seizures or epilepsy.
  • I have another neurological or psychiatric condition.
  • I have an active substance use disorder in the past 6 months, except for tobacco.
  • I cannot give my consent for the study.
  • I have a pacemaker.
  • I have a coronary stent.
  • I have a defibrillator.
  • I have uncontrolled high blood pressure.

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The purpose of this study is to examine whether cerebellar stimulation can be used to improve cognitive deficits and mood in patients with schizophrenia, autism, bipolar disorder, Parkinson's disease, and major depression.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * A clinical diagnosis consistent with enrollment Exclusion Criteria: * History of recurrent seizures or epilepsy * Any other neurological or psychiatric diagnosis outside the diagnosis for which the participant is enrolled. * Active substance use disorder in the past 6 months…
Contacts

Krystal L Parker, Ph.D

319-353-4554

CT201610712@gmail.com

CONTACT

Benjamin Pace, M.S.

319-384-9302

benjamin-pace@uiowa.edu

CONTACT